Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin beta-16 is a neural cadherin-like cell adhesion protein encoded by the PCDHB16 gene, which is part of the protocadherin beta gene cluster located on chromosome 5. The protein contains six extracellular cadherin domains and is believed to be a potential calcium-dependent cell-adhesion molecule. Although its precise functions remain to be fully elucidated, it is highly expressed in the brain and likely involved in the establishment and maintenance of specific neuronal cell-cell connections. Mutations or altered expression of PCDHB16 have been noted in the context of neurodevelopmental disorders, including autism spectrum disorder. Unlike classical cadherins, protocadherin beta family members like PCDHB16 are encoded by a single large exon and do not share common 3’ exons. They are considered integral plasma membrane proteins with critical roles in neural connectivity but are not recognized therapeutic drug targets at this time[1][2][3][5][6][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin beta-16 (PCDHB16).